BerGenBio
BGBIO | OL
Overview
Corporate Details
- ISIN(s):
- NO0012921180 (+2 more)
- LEI:
- 213800TYYFXKYF3V2A23
- Country:
- Norway
- Address:
- MØLLENDALSBAKKEN 9, 5009 BERGEN
- Website:
- https://www.bergenbio.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
BerGenBio is a clinical-stage biopharmaceutical company developing innovative drugs for aggressive diseases, including cancer and severe respiratory infections. AXL: a promising target to treat life-threatening diseases The tyrosine kinase target AXL is known to play an important role in both the innate and adaptive immune systems, BerGenBio is developing two highly selective AXL inhibitors bemcentinib and tilvestamab. Business model: R&D excellence and strategic partnerships BerGenBio is leveraging its solid leadership position in understanding the role of AXL and related kinase signalling in diseases of high unmet need to develop a diversified pipeline of selective AXL inhibitors.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-03 14:53 |
Regulatory News Service
BerGenBio ASA: Notice of Extraordinary General Meeting - Attachment: BerGenBio_…
|
Norwegian | 441.1 KB | |
| 2025-07-03 14:53 |
General Meeting Notice
BerGenBio ASA: Notice of Extraordinary General Meeting
|
English | 2.6 KB | |
| 2025-06-30 22:30 |
Regulatory News Service
BerGenBio ASA - Key information related to the rights issue
|
English | 10.0 KB | |
| 2025-06-30 22:05 |
Investment Company Reports
Announcement of fully underwritten rights issue - Attachment: Attachment_overvi…
|
English | 101.2 KB | |
| 2025-06-30 22:05 |
Inside Information Statement
Announcement of fully underwritten rights issue
|
English | 21.0 KB | |
| 2025-06-30 22:00 |
Regulatory News Service
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer ther…
|
English | 19.5 KB | |
| 2025-06-26 11:29 |
Declaration of Voting Results & Voting Rights Announcements
BerGenBio ASA - Minutes from the annual general meeting 2025 - Attachment: BerG…
|
Norwegian | 419.9 KB | |
| 2025-06-26 11:29 |
Declaration of Voting Results & Voting Rights Announcements
BerGenBio ASA - Minutes from the annual general meeting 2025
|
English | 1.1 KB | |
| 2025-06-03 19:22 |
Regulatory News Service
BerGenBio ASA: Update on Strategic Review Process and Status of Activities
|
English | 2.6 KB | |
| 2025-06-03 15:55 |
General Meeting Notice
BerGenBio ASA: Notice of Annual General Meeting - Attachment: Notice_of_AGM_Ber…
|
Norwegian | 424.8 KB | |
| 2025-06-03 15:55 |
General Meeting Notice
BerGenBio ASA: Notice of Annual General Meeting
|
English | 2.6 KB | |
| 2025-04-30 07:51 |
General Meeting Notice
Financial calendar
|
English | 666 bytes | |
| 2025-04-29 20:03 |
Annual Report (ESEF)
BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Rep…
|
English | 3.9 MB | |
| 2025-04-29 20:03 |
Annual Report
BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Rep…
|
English | 2.8 MB | |
| 2025-04-29 20:03 |
Report Publication Announcement
BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Rep…
|
English | 2.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |